Dental Care Clinics in Kingsburg, CA Accepting Medicare
5 Dental Care Clinics found. Showing 1 - 5
 Kingsburg Family Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1064 Lewis St, Kingsburg, CA 93631 Phone: 559-897-2600 Fax: 559-897-2622 |
Kingsburg Smile Center Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1591 Earl St, Kingsburg, CA 93631 Phone: 559-897-5042 |
B. Fareid Dds Dba Kingsburg Smile Center Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1591 Earl St, Kingsburg, CA 93631 Phone: 559-897-5042 Fax: 559-897-5041 |
H S Mann Dds Inc Dentist Medicare: Not Enrolled in Medicare Practice Location: 1518 Draper St, Kingsburg, CA 93631 Phone: 559-897-4111 Fax: 559-897-3151 |
Neikka Fareid, D.d.s. A Professional Corporation Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1591 Earl St, Kingsburg, CA 93631 Phone: 559-897-5042 |
News Archive
Researchers find way to enhance effects of immunotherapy in glioblastoma
When cancer strikes, it may be possible for patients to fight back with their own defenses, using a strategy known as immunotherapy. According to a new study published in Nature, researchers have found a way to enhance the effects of this therapeutic approach in glioblastoma, a deadly type of brain cancer, and possibly improve patient outcomes.
Bacterin to distribute Jeil's LeForte craniomaxillofacial system in the U.S. and Canada
Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, signed an exclusive agreement with Jeil Medical Corporation for distribution in the U.S. and Canada of Jeil's LeForte System.
Immtech and BioAlliance sign agreement on Pafuramidine for African sleeping sickness
Immtech Pharmaceuticals has announced that the Company has granted an exclusive license to BioAlliance Pharma SA to commercialize Immtech's oral drug, pafuramidine maleate (pafuramidine), in Europe for the treatment of pneumocystis pneumonia (PCP) in AIDS patients and for the treatment of Human African trypanosomiasis, also known as African sleeping sickness.
Macrocure's CureXcell Shows Strong Efficacy and Safety in Phase IV Hard-To-Heal Wounds Trial
Cell therapy demonstrates high rate of complete closure of hard-to-heal wounds, including diabetic foot (DFU) and venous ulcers.
Experts clarify MS subtypes to improve care and access to treatments
An international committee of multiple sclerosis (MS) experts has clarified their previously published descriptors of the different courses of MS and disease activity.
› Verified 5 days ago